In the BioHarmony Drug Report Database

"Preview" Icon

Insulin glargine

Basaglar, Lantus, Semglee, Toujeo, Optisulin (insulin glargine) is a protein pharmaceutical. Insulin glargine was first approved as Basaglar on 2000-04-20. It is used to treat hyperglycemia, type 1 diabetes mellitus, and type 2 diabetes mellitus in the USA. It has been approved in Europe to treat diabetes mellitus.


Trade Name


Lantus, Optisulin, Toujeo

Common Name


insulin glargine






diabetes mellitus, hyperglycemia, type 1 diabetes mellitus, type 2 diabetes mellitus

Drug Class


Image (chem structure or protein)

Insulin glargine structure rendering